Assessing Bioavailability of CoQ10 Supplementation in Intensive Care Patients

Assessing Bioavailability of CoQ10 Supplementation in Intensive Care Patients - CoQ10 Supplementation in ICU patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018718

Enrollment

Registered

2015-08-24

Start date

2015-08-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease

Interventions

Supplementation of reduced CoQ10 Supplementation of placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preoperative patients for cardiovascular surgery using cardiopulmonary bypass with postoperative admission to the ICU.

Exclusion criteria

Exclusion criteria: Pregnant women, patients unable to communicate and patients with soy beans allergy.

Design outcomes

Primary

Measure	Time frame
Plasma and intracellular coenzyme Q10 levels and inflammatory cytokine levels	—

Countries

Japan,North America

Contacts

Public ContactTomoyuki Nakamura

Fujita Health University Department of Anesthesiology and Critical Care Medicine

tomo-n@fujita-hu.ac.jp0562-93-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026